Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Stem Cell|June 3, 2018
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic LeukemiaMichael Y Choi, George F Widhopf, Emanuela M Ghia, et al.
Cancer Research|April 21, 2011
Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancerVered Padler-Karavani, Nancy Hurtado-Ziola, Minya Pu, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Breast Cancer Research : BCR|February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
JCI Insight|October 26, 2016
Systems biology analysis reveals role of MDM2 in diabetic nephropathyRintaro Saito, Anaïs Rocanin-Arjo, Young-Hyun You, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trialEllen B Gold, John P Pierce, Loki Natarajan, et al.
Journal of the American Society of Nephrology : JASN|August 17, 2013
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney diseaseKumar Sharma, Bethany Karl, Anna V Mathew, et al.
Pageof 8